tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TAK Stock Latest News

Takeda Continues Incentive Plans to Boost Performance
Company AnnouncementsTakeda Continues Incentive Plans to Boost Performance
1d ago
6K
TAK
Takeda Pharmaceutical Announces Board Member’s Passing
PremiumCompany Announcements
Takeda Pharmaceutical Announces Board Member’s Passing
1d ago
6K
TAK
Takeda Targets Growth and Profitability Boost
PremiumCompany Announcements
Takeda Targets Growth and Profitability Boost
1d ago
6K
TAK
Takeda Exceeds Financial Forecasts for FY2024
PremiumCompany Announcements
Takeda Exceeds Financial Forecasts for FY2024
1d ago
6K
TAK
Takeda Focuses on Core Financial Clarity
PremiumCompany Announcements
Takeda Focuses on Core Financial Clarity
1d ago
6K
TAK
Denali Therapeutics reports Q1 EPS (68c), consensus (70c)
PremiumThe FlyDenali Therapeutics reports Q1 EPS (68c), consensus (70c)
3d ago
SNY
TAK
Takeda announces CHMP opinion recommending approval of fruquintinib
PremiumThe Fly
Takeda announces CHMP opinion recommending approval of fruquintinib
14d ago
TAK
Hutchmed announces positive CHMP opinion for fruquintinib
PremiumThe Fly
Hutchmed announces positive CHMP opinion for fruquintinib
14d ago
HCM
TAK
Takeda, Astellas Pharma and Sumitomo Mitsui to establish joint venture company
PremiumThe Fly
Takeda, Astellas Pharma and Sumitomo Mitsui to establish joint venture company
18d ago
TAK
SMFG
FDA Approves New Takeda Drug Delivery Option
PremiumCompany Announcements
FDA Approves New Takeda Drug Delivery Option
21d ago
6K
TAK
FDA approves subcutaneous administration of Takeda’s ENTYVI in Crohn’s disease
PremiumThe Fly
FDA approves subcutaneous administration of Takeda’s ENTYVI in Crohn’s disease
22d ago
TAK
Takeda Announces Issuance of Innovative Hybrid Bonds
PremiumCompany Announcements
Takeda Announces Issuance of Innovative Hybrid Bonds
25d ago
6K
TAK
Takeda selects eight U.S. non-profit organizations as grant recipients
PremiumThe FlyTakeda selects eight U.S. non-profit organizations as grant recipients
1M ago
TAK
Takeda Reveals Board Candidates for Shareholders’ Vote
PremiumCompany Announcements
Takeda Reveals Board Candidates for Shareholders’ Vote
1M ago
6K
TAK
Japan approves Takeda’s ADZYNMA to treat ‘ultra-rare’ disorder cTTP
PremiumThe Fly
Japan approves Takeda’s ADZYNMA to treat ‘ultra-rare’ disorder cTTP
2M ago
TAK
Scilex announces agreement with Takeda to resolve patent infringement lawsuit
PremiumThe Fly
Scilex announces agreement with Takeda to resolve patent infringement lawsuit
2M ago
TAK
SCLX
Takeda announces FDA approval of supplemental indication for Iclusig
PremiumThe Fly
Takeda announces FDA approval of supplemental indication for Iclusig
2M ago
TAK
Takeda leukemia treatment granted accelerated approval by FDA
PremiumThe Fly
Takeda leukemia treatment granted accelerated approval by FDA
2M ago
TAK
Centogene extends partnership with Takeda
PremiumThe Fly
Centogene extends partnership with Takeda
2M ago
TAK
CNTG
Protagonist closes rusfertide license, collaboration agreement with Takeda
PremiumThe FlyProtagonist closes rusfertide license, collaboration agreement with Takeda
2M ago
TAK
PTGX
Takeda announces results from Phase 2 study of mezagitamab as antibody for ITP
PremiumThe Fly
Takeda announces results from Phase 2 study of mezagitamab as antibody for ITP
2M ago
TAK
Takeda price target raised to $14.30 from $13.70 at JPMorgan
PremiumThe Fly
Takeda price target raised to $14.30 from $13.70 at JPMorgan
2M ago
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >